Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells
2016 ◽
2020 ◽
Vol 185
◽
pp. 111748
◽
2020 ◽
Vol 195
◽
pp. 112258
◽
Keyword(s):
2004 ◽
Vol 32
(1)
◽
pp. 262-269
◽
Keyword(s):
2010 ◽
Vol 70
(3)
◽
pp. 1042-1052
◽
2009 ◽
Vol 8
(9)
◽
pp. 2509-2516
◽
Keyword(s):